logologo
QuantliQuantli

Viridian Therapeutics Inc

VRDN

NASDAQ

Biotechnology

$22.08

USD

+0.09 (+0.41%)

At close: Aug 14, 2026, 4:00 PM EDT

Market Cap $2.48B

Volume 1.1M

Price Target

$31.00$43.00

USD

The 5 analysts offering 1-year price forecasts have a max estimate of $43.00 and a min estimate of $31.00.

Price (USD)
Price (USD)

Past 2Y

1Y Forecast

Price Targets

Average Target

$36.20

+$7.6 vs prior

Implied Upside

+64.0%

+34.3% vs prior

Analyst Covering

5

-3 vs prior period

Consensus

Buy

Improved vs prior

Signal Quality

Consensus Freshness

38%

Many ratings are older - consensus may be less current

Analyst Agreement

Moderate

Targets show moderate spread across analysts

Mean vs Median

$1.20 Gap

Median $35.00 vs avg $36.20 - a few bullish outliers are pulling the average up

Analyst Consensus

Strong Sell

Hold

Strong Buy

Buy

5 Buy

0 Hold

0 Sell

Rating Breakdown

Strong Buy

0

Buy

5

Hold

0

Sell

0

Strong Sell

0

5 analysts · last 3 months

Covering Analysts

Unlock each analyst's profile, success rate + price targets

Free shows the consensus and each analyst's current rating.

AnalystFirmRatingActionDateSuccess RatePrice TargetImplied Upside

Serge Belanger

Needham

Buy

Maintained

1 month ago

Plus
Plus
Plus

Laura Chico

Wedbush

Buy

Maintained

1 month ago

Plus
Plus
Plus

Gregory Renza

Truist Securities

Buy

Maintained

1 month ago

Plus
Plus
Plus

Lisa Walter

RBC Capital

Buy

Maintained

1 month ago

Plus
Plus
Plus

Derek Archila

Wells Fargo

Buy

Upgraded

1 month ago

Plus
Plus
Plus

Frequently Asked Questions

Similar Stocks

AGIO

Agios Pharmaceuticals Inc

$33.56

+0.3%

ADMA

ADMA Biologics Inc

$9.47

+0.6%

ZBIO

Zenas Biopharma Inc

$29.51

+1.1%

DMRA

Damora Therapeutics Inc

$31.04

+1.0%

STOK

Stoke Therapeutics Inc

$31.27

-0.1%

TSHA

Taysha Gene Therapies Inc

$5.95

-0.7%

PGEN

Precigen Inc

$6.10

-6.0%

GENB

Generate Biomedicines Inc

$15.64

+4.1%